Indian markets, which were trending up earlier in the week, fell on strong negative news from the US – tough talk by the US Federal Reserve on interest rates and the collapse of Silicon Valley Bank.
Eugia Pharma Specialities Ltd, subsidiary of Aurobindo Pharma Ltd has received a final approval from the USFDA to manufacture and market Lenalidomide Capsules, 2.5 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 25 mg
On Wednesday, on the Bombay Stock Exchange (BSE), 1628 stocks advanced, 1498 declined and 145 remained unchanged with advance decline ratio of 1.08, indicating a positive closing of stocks in broader markets.